Background Obstructive sleep apnea (OSA) is a risk factor for several diseases and is
correlated with other non-medical consequences that increase the disease's clinical and …

Excessive daytime sleepiness (EDS) is common in patients with obstructive sleep apnea
(OSA) and continues to persist in many patients despite adequate OSA treatment. EDS in …

Costs of untreated OSA may double the medical expenses mainly because of CVD.
Identifying the costliest, sickest upper third of OSA patients will reduce expenses to …

Obstructive sleep apnea (OSA) is a common and costly medical condition. Untreated OSA is
associated with numerous and well-documented adverse health consequences including …

Obstructive sleep apnea syndrome (OSA) alters sleep quality and is associated with
sleepiness and decreased cognitive functioning. It has therefore always been recognized as …

Two new white papers commissioned by the American Academy of Sleep Medicine (AASM)
provide an in-depth, detailed analysis of the vast economic burden associated with …

Obstructive sleep apnea (OSA) is a disorder characterized by intermittent upper-airway
collapse, which impairs ventilation and disrupts sleep. Factors that contribute to upper …

Abstract Study Objectives To determine cost-effectiveness of continuous positive airway
pressure (CPAP) treatment of obstructive sleep apnea (OSA) in Australia for 2017–2018 to …

This paper reviews some concepts on health economics from the authors personal
perspective. It then examines the few papers published on health economics analysis …

ABSTRACT The International Classification of Sleep Disorders distinguishes more than 80
different disorders, which can be effectively treated. Problems with falling asleep or daytime …